Cargando…
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
Aberrant activation of intracellular signalling pathways confers malignant properties on cancer cells. Targeting intracellular signalling pathways has been a productive strategy for drug development, with several drugs acting on signalling pathways already in use and more continually being developed...
Autores principales: | Thomas, S J, Snowden, J A, Zeidler, M P, Danson, S J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522639/ https://www.ncbi.nlm.nih.gov/pubmed/26151455 http://dx.doi.org/10.1038/bjc.2015.233 |
Ejemplares similares
-
Methotrexate Is a JAK/STAT Pathway Inhibitor
por: Thomas, Sally, et al.
Publicado: (2015) -
A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
por: McInnes, Iain B, et al.
Publicado: (2021) -
Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome
por: Li, Mucong, et al.
Publicado: (2023) -
The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
por: Rusek, Marta, et al.
Publicado: (2023) -
The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)